Autism spectrum disorder prevalence in Italy: a nationwide study promoted by the Ministry of Health.
Autism spectrum disorder
Epidemiology
Multistage screening
Prevalence estimate
Journal
Child and adolescent psychiatry and mental health
ISSN: 1753-2000
Titre abrégé: Child Adolesc Psychiatry Ment Health
Pays: England
ID NLM: 101297974
Informations de publication
Date de publication:
28 Oct 2023
28 Oct 2023
Historique:
received:
26
08
2023
accepted:
15
10
2023
medline:
29
10
2023
pubmed:
29
10
2023
entrez:
29
10
2023
Statut:
epublish
Résumé
This nationwide study aimed to estimate Autism Spectrum Disorder (ASD) prevalence in 7-9-year-old Italian children. Promoted by Italy's Ministry of Health and coordinated by the National Observatory for Autism at the National Institute of Health, it covered schools in northern (Lecco and Monza-Brianza), central (Rome and its province), and southern (Palermo and its province) regions from February 24, 2016, to February 23, 2018, using a multi-stage approach defined by the European Union's ASD network. Phase one identified ASD-diagnosed children in mainstream schools through local Ministry of Education (MoE) disability registries. Phase two had a subset of schools screen 7-9-year-olds using the Social Communication Questionnaire-Life version (SCQ-L). Those with SCQ-L scores of 15 + underwent clinical consultation for ASD symptoms, cognitive abilities, and life skills. To counter potential false negatives, 20% scoring 11-14 were randomly assessed via Autism Diagnostic Interview-Revised (ADI-R). MoE data revealed 9.8 per 1000 certified ASD children in the north, 12.2 in the central, and 10.3 in the south. In phase two, 35,823 SCQ-L questionnaires were distributed across 198 schools (northern: 11,190 in 49 schools, central: 13,628 in 87 schools, southern: 11,005 in 62 schools). Of SCQ-L respondents, 2.4% (n = 390) scored above the 15 cutoff. Among these, 100 had ASD diagnoses, and 50 had other diagnoses. Among 115 families assessed, 16.5% (n = 19) received ASD diagnoses. The estimated prevalence of ASD in Italy was 13.4 (11.3-16.0) per 1,000 children aged 7-9 years, with a male-to-female ratio of 4.4:1. It will guide national policies in enhancing services tailored to the specific needs of autistic children.
Sections du résumé
BACKGROUND
BACKGROUND
This nationwide study aimed to estimate Autism Spectrum Disorder (ASD) prevalence in 7-9-year-old Italian children. Promoted by Italy's Ministry of Health and coordinated by the National Observatory for Autism at the National Institute of Health, it covered schools in northern (Lecco and Monza-Brianza), central (Rome and its province), and southern (Palermo and its province) regions from February 24, 2016, to February 23, 2018, using a multi-stage approach defined by the European Union's ASD network.
METHODS
METHODS
Phase one identified ASD-diagnosed children in mainstream schools through local Ministry of Education (MoE) disability registries. Phase two had a subset of schools screen 7-9-year-olds using the Social Communication Questionnaire-Life version (SCQ-L). Those with SCQ-L scores of 15 + underwent clinical consultation for ASD symptoms, cognitive abilities, and life skills. To counter potential false negatives, 20% scoring 11-14 were randomly assessed via Autism Diagnostic Interview-Revised (ADI-R).
RESULTS
RESULTS
MoE data revealed 9.8 per 1000 certified ASD children in the north, 12.2 in the central, and 10.3 in the south. In phase two, 35,823 SCQ-L questionnaires were distributed across 198 schools (northern: 11,190 in 49 schools, central: 13,628 in 87 schools, southern: 11,005 in 62 schools). Of SCQ-L respondents, 2.4% (n = 390) scored above the 15 cutoff. Among these, 100 had ASD diagnoses, and 50 had other diagnoses. Among 115 families assessed, 16.5% (n = 19) received ASD diagnoses.
CONCLUSIONS
CONCLUSIONS
The estimated prevalence of ASD in Italy was 13.4 (11.3-16.0) per 1,000 children aged 7-9 years, with a male-to-female ratio of 4.4:1. It will guide national policies in enhancing services tailored to the specific needs of autistic children.
Identifiants
pubmed: 37898807
doi: 10.1186/s13034-023-00673-0
pii: 10.1186/s13034-023-00673-0
pmc: PMC10613370
doi:
Types de publication
Journal Article
Langues
eng
Pagination
125Subventions
Organisme : Ministero della Salute
ID : 6S02
Organisme : European Parliament
ID : SANCO/2014/C2/035
Informations de copyright
© 2023. The Author(s).
Références
Pediatr Res. 2009 Jun;65(6):591-8
pubmed: 19218885
Brain Sci. 2020 May 01;10(5):
pubmed: 32370097
J Am Acad Child Adolesc Psychiatry. 2017 Apr;56(4):313-320
pubmed: 28335875
Ir J Med Sci. 2009 Jun;178(2):193-9
pubmed: 18651205
J Autism Dev Disord. 2009 Jun;39(6):897-909
pubmed: 19205862
Autism Res. 2022 May;15(5):778-790
pubmed: 35238171
J Autism Dev Disord. 2020 Mar;50(3):949-959
pubmed: 31813107
J Autism Dev Disord. 2007 Aug;37(7):1272-8
pubmed: 17080270
Epidemiol Psychiatr Sci. 2018 Sep 06;29:e5
pubmed: 30187843
J Am Acad Child Adolesc Psychiatry. 2007 May;46(5):636-646
pubmed: 17450055
Autism. 2017 Nov;21(8):920-928
pubmed: 27503464
Mol Psychiatry. 2020 Dec;25(12):3178-3185
pubmed: 32355335
Ann Epidemiol. 2016 Jun;26(6):395-400
pubmed: 27230493
Eur Child Adolesc Psychiatry. 2021 Apr;30(4):579-589
pubmed: 32388625
Lancet. 2022 Jan 15;399(10321):271-334
pubmed: 34883054
Eur Child Adolesc Psychiatry. 2014 Nov;23(11):1005-21
pubmed: 24913785
Autism Res. 2012 Jun;5(3):160-79
pubmed: 22495912
Natl Health Stat Report. 2015 Nov 13;(87):1-20
pubmed: 26632847
MMWR Surveill Summ. 2023 Mar 24;72(2):1-14
pubmed: 36952288
J Child Psychol Psychiatry. 2007 Sep;48(9):932-40
pubmed: 17714378
Lancet Psychiatry. 2019 Jul;6(7):590-600
pubmed: 31230684
MMWR Surveill Summ. 2018 Apr 27;67(6):1-23
pubmed: 29701730